However, as neurturin appears to mediate the majority of the effects of PGC1α1, it may be that it is the subsequent loss of neurturin that renders the loss of PGC1α detrimental in ALS. This evidence concerns the gene PPARGC1A and amyotrophic lateral sclerosis.